Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/36552
Conference/Presentation Title: A randomized control study comparing retropubic mid-urethral sling (TVT) vs. trans-obturator tape (MONARC) in the treatment of women with USI and ISD. Long term follow up with mean of 12 years. [Female Pelvic Medicine and Reconstructive Surgery]
Authors: Rosamilia A.;Dwyer P.L.;Murray C.;Hiscock R.;Thomas E.;Schierlitz L.
Institution: (Schierlitz, Dwyer) Mercy Hospital for Women, Melbourne, VIC, Australia (Rosamilia) Monash Medical Centre, Melbourne, VIC, Australia (Murray, Thomas, Hiscock) Mercy Hospital for Women, Heidelberg, VIC, Australia
Presentation/Conference Date: 19-Sep-2019
Copyright year: 2019
Publisher: Lippincott Williams and Wilkins
Publication information: Female Pelvic Medicine and Reconstructive Surgery. Conference: 2019 Annual Scientific Meetings of the American Urogynecologic Society, AUGS and the International Urogynecological Association, IUGA. Nashville, TN United States. 25 (5 Supplement 1) (pp S6-S7), 2019. Date of Publication: September - October 2019.
Abstract: Objective: Comparison of the efficacy of retropubic (RP)to transobturator tape (TOT) mid-urethral sling (MUS) in the treatment of women with stress urinary incontinence (SUI) and intrinsic sphincter deficiency (ISD) with a minimum follow up of 12 years. Method(s): 164 women were randomized to either receive RP or TOT MUS as treatment of urodynamic stress incontinence and intrinsic sphincter deficiency. Concomitant pelvic organ prolapse surgery was admissible. The primary outcome assessed after >=12 years follow-up was symptomatic SUI requiring repeat surgery. Secondary outcomes were assessed by phone interview and validated questionnaires evaluating quality of life. The question, if the procedure would be recommended to a family friend or relative was asked. Result(s): 164 women were enrolled and randomized to one of the MUS. 12 years after enrollment, 1 of the 82 (1.2 %) in the RP group had undergone repeat surgery to correct SUI compared to 20 of the 82 (24.4%) women in the TOT group. The repeat surgeries consisted of 20 RPMUS placements and 1 pubovaginal sling (in TOT group). If RPMUS had been used exclusively, repeat surgery for SUI would have been avoided in one in 5 (95%CI 4 to 8) patients. The risk ratio of repeat surgery was 19 (95%CI 3 to 139 p < 0.001) times greater in the TOT group. In the TOT group, the median time to repeat surgery was 32 months compared with 43 months for RP group (P<0.46). Results such as recurrent SUI, overactive bladder symptoms and complications are reported in Table 1. The quality-of-life outcomesUDI 6 (total&subscores questions 2,3 &5) and IIQ7 were not different either between groups or across duration of follow-up inwomen not requiring repeat sling. The positive reply to recommending the surgery to a friend was similar in both groups. The rate of surgery for complications was 2-3%. Conclusion(s): The cure rate for urodynamic SUI with ISD is significantly higher for the RP compared with the TOT MUS. Urodynamic assessment of urethral closure pressure and Valsalva leak point pressures appears to be of value in the identification of the women in the subgroup with USI and ISD who would benefit from the retropubic route at the time of MUS insertion.(Figure Presented).
Conference Start Date: 2019-09-24
Conference End Date: 2019-09-28
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1097/SPV.0000000000000768
ISSN: 2154-4212
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/36552
Type: Conference Abstract
Type of Clinical Study or Trial: Randomised controlled trial
Appears in Collections:Conferences

Show full item record

Page view(s)

4
checked on Sep 27, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.